Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7971444 | 0.78 | MAOA (0.67) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL7561578 | 0.72 | CA2 (0.54) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| Tazofelone SCHEMBL7561505 | 0.70 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| Tazofelone SCHEMBL7562446 | 0.70 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| Tazofelone SCHEMBL380266 | 0.70 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL8532155 | 0.70 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL10369918 | 0.70 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL7971450 | 0.69 | ALDH1A1 (0.43) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL7796811 | 0.69 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL13463340 | 0.68 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210038566-A1 | USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION | ENYO PHARMA (FR) | 2021-02-11 | — | — | US | disclosed |
| WO-2019154958-A1 | USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION | ENYO PHARMA (FR) | 2019-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210038566-A1 | USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION | PEBP1, ELANE, MME | ALDH1A1 4666/4885TSHR 4000/4885MAPK1 3621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.